Tango Therapeutics
Latest round
- Series B
Last raised
- Apr 2020
Total raised
- $115M
Investors
- 4
About Tango Therapeutics
Tango Therapeutics, Inc. is dedicated to advancing cancer therapies via synthetic lethality. Founded in 2017, the company is headquartered in Cambridge, US. Tim Lu serves as the founder, and Barbara Weber is the current CEO.Tango Therapeutics specializes in developing therapies that leverage synthetic lethality to target specific tumors, addressing critical needs in oncology.10 mn. This strategic initiative may include the development and launch of new products targeting specific cancers. Moreover, Tango aims to enhance its presence in new markets, particularly focusing on North America and Europe, where the need for innovative cancer therapies is increasing.
Who invested in Tango Therapeutics
4 investors across 2 rounds
See all investors in Tango Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Tango Therapeutics
Who invested in Tango Therapeutics?
Tango Therapeutics has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tango Therapeutics raised?
Tango Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Tango Therapeutics last raise money?
Tango Therapeutics's most recent round on record is a Series B, in Apr 2020.
What does Tango Therapeutics do?
Tango Therapeutics is a biotechnology company.
Where is Tango Therapeutics headquartered?
Tango Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Tango Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Tango Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Tango Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.